IMPROVE-CABG: Impact of Perivascular Tissue on Endothelial Function in Coronary Artery Bypass Grafting

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01834846
Collaborator
St. Olavs Hospital (Other)
100
1
2
103
1

Study Details

Study Description

Brief Summary

The success of coronary artery bypass grafting is reliant on the quality of the grafts used. A new technique for harvesting veins used as grafts has been introduced. The study hypothesis is that veins harvested with this technique have an improved endothelial function.

Condition or Disease Intervention/Treatment Phase
  • Procedure: no-touch
  • Procedure: conventional
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Impact of Perivascular Tissue on Endothelial Function and Vessel Structure in Vein Grafts Used for Coronary Artery Bypass Grafting: A Prospective, Randomized Controlled Trial.
Actual Study Start Date :
May 1, 2013
Actual Primary Completion Date :
Dec 1, 2016
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: no-touch

no-touch technique of harvesting the saphenous vein graft for coronary artery bypass grafting

Procedure: no-touch
The saphenous vein is exposed by a longitudinal incision, and all visible side branches ligated. The vein is then isolated together with a pedicle of surrounding tissue and manually distended and stored in a combination of blood and saline using a syringe, according to standard procedure at St. Olav's Hospital.

Active Comparator: conventional

conventional technique of harvesting the saphenous vein graft for coronary artery bypass grafting

Procedure: conventional
The saphenous vein is exposed by a longitudinal leg incision, skeletonized from surrounding tissue, and side branches ligated. The vein is removed from the leg immediately after dissection, manually distended and stored in a combination of blood and saline using a syringe, according to standard procedure at St. Olav's Hospital.

Outcome Measures

Primary Outcome Measures

  1. Graft function [6 months]

    Graft function as evaluated by coronary angiography in the first 60 out of 100 patients

  2. Graft function [5 years]

    Graft function as evaluated by coronary angiography in all 100 patients

Secondary Outcome Measures

  1. Morphological appearance of vein graft [6 months]

    As measured by angiography follow-up in the first 60 out of 100 patients

  2. Morphological appearance of vein graft [5 years]

    As measured by angiography follow-up in all 100 patients

  3. Postoperative leg wound complications [6 weeks]

    The following measures will be assessed in the first 60 out of 100 patients: Signs of infection Wound dehiscence Aesthetics Cutaneous sensory loss Wound discomfort

  4. Postoperative complications related to cardiac surgery [Discharge, 6 weeks, 6 months]

    Major adverse cardiac and cerebral events in the first 60 out of 100 patients Postoperative complications Reoperation Sternal dehiscence Mediastinitis

  5. Postoperative complications related to cardiac surgery [5 years]

    Major adverse cardiac and cerebral events in all 100 patients Postoperative complications Reoperation Sternal dehiscence Mediastinitis

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Isolated elective, primary CABG requiring cardiopulmonary bypass

  • Left ventricular ejection fraction >35%

  • at least one saphenous vein graft required as part of revascularization strategy

Exclusion Criteria:
  • Acute or chronic inflammatory diseases

  • Malignancies

  • Pregnancy

  • Previous cardiac surgery

  • Serum creatinine >120 μmol/L

  • Coagulopathy

  • Insulin dependent diabetes mellitus

  • Smoking during last 6 months

  • Leg not suitable for No-touch vein harvesting as judged by the operator.

  • Need for nitrates on operation day

  • not receiving statins

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute for Circulation and Imaging Trondheim Sør-Trøndelag Norway 7042

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • St. Olavs Hospital

Investigators

  • Principal Investigator: Dag Ole Nordhaug, md phd, Norwegian University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01834846
Other Study ID Numbers:
  • 090486
First Posted:
Apr 18, 2013
Last Update Posted:
Jan 5, 2021
Last Verified:
Dec 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2021